Targeting Bcl-2 in CLL

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|19|30|5109-5115

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.19, Iss.30, 2012-10, pp. : 5109-5115

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the Bcl-2 family for cancer therapy

By Thomas Shibu   Quinn Bridget A   Das Swadesh K   Dash Rupesh   Emdad Luni   Dasgupta Santanu   Wang Xiang-Yang   Dent Paul   Reed John C   Pellecchia Maurizio   Sarkar Devanand   Fisher Paul B  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 1, 2013-01 ,pp. : 61-75

Informa Healthcare

Access to resources Recommend Favorite

Targeting the BCL-2 family in malignancies of germinal centre origin

By Spender Lindsay C   Inman Gareth J  

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 12, 2009-12 ,pp. : 1459-1472

Informa Healthcare

Access to resources Recommend Favorite

New Treatment Strategies for Multiple Myeloma by Targeting BCL-2 and the Mevalonate Pathway

By  

Current Pharmaceutical Design, Vol. 12, Iss. 3, 2006-01 ,pp. : 327-340

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Bcl-2 in Herceptin-Resistant Breast Cancer Cell Lines

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 9, Iss. 3, 2011-09 ,pp. : 184-190

Bentham Science Publishers

Access to resources Recommend Favorite

Let-7c sensitizes acquired cisplatin-resistant A549 cells by targeting ABCC2 and Bcl-XL

By Zhan Min   Qu Qiang   Wang Guo   Zhou Honghao  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 68, Iss. 12, 2013-12 ,pp. : 955-961

Govi-Verlag

Access to resources Recommend Favorite